Triglyceride-Glucose Index: A Candidate Prognostic Marker in HR-Positive/HER2-Negative Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors

Autor: Önder, Tuğba, Ateş, Öztürk, Öner, İrem, Karaçin, Cengiz
Zdroj: In Clinical Breast Cancer August 2024 24(6):519-526
Databáze: ScienceDirect